What is Arboris?
Arboris, LLC stands as the preeminent global producer of plant sterols, naturally derived compounds renowned for their cholesterol-reducing properties. Sourced from pine trees, a sustainable and renewable resource, Arboris' plant sterols are processed into a 99% pure mixture of naturally occurring phytosterols. These high-purity ingredients are integral to a wide array of food products, including spreads, juices, bread, and dairy items. The company's commitment to quality and its non-GMO sourcing appeal to a discerning customer base that prioritizes purity and adherence to stringent manufacturing standards.
How much funding has Arboris raised?
Arboris has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Arboris
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Arboris?
The recent major strategic investment signals Arboris' readiness to scale its operations and potentially expand its product applications or market reach. This capital will likely fuel advancements in production capacity, research and development for new applications of plant sterols, or strategic partnerships to broaden distribution. As a leader in naturally derived cholesterol-reducing compounds, Arboris is well-positioned to capitalize on the growing consumer demand for healthier food ingredients and functional foods.
See full Arboris company page
